The forkhead transcription factor FOXP1 represses human plasma cell differentiation

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• Forkhead transcription factor FOXP1 is crucial for early B-cell development.
• Downregulation of FOXP1 at the germinal center stage is necessary for B-cell function.
• Elevated FOXP1 expression is linked to poor prognosis in diffuse large B-cell and mucosa-associated lymphoid tissue lymphomas.

Purpose of the Study:

• To investigate the role of FOXP1 in regulating plasma cell differentiation.
• To determine if FOXP1 directly represses key regulators of plasma cell differentiation.
• To explore the impact of FOXP1 dysregulation on B-cell lymphomagenesis.

Main Methods:

• Gene expression analysis of primary human memory B cells and B-cell lines with ectopic FOXP1 overexpression.
• Chromatin immunoprecipitation and sequencing (ChIP-seq) to identify FOXP1 direct targets.
• Comparison of FOXP1 expression and plasma cell differentiation propensity in different B-cell subsets (IgM+ vs. IgG+ MBCs).

Main Results:

• FOXP1 directly represses the expression of PRDM1, IRF4, and XBP1, which are master regulators of plasma cell differentiation.
• FOXP1 expression is high in naive and memory B cells but decreases significantly during plasma cell differentiation.
• IgG+ memory B cells exhibit lower FOXP1 expression and higher plasma cell differentiation potential compared to IgM+ memory B cells.
• Overexpression of FOXP1 inhibits the ability of B cells to differentiate into plasma cells.

Conclusions:

• Precise regulation of FOXP1 expression is essential for effective plasma cell differentiation.
• Aberrant FOXP1 expression can impede terminal B-cell differentiation, potentially contributing to the development of B-cell lymphomas.
• FOXP1's role in blocking plasma cell differentiation may underlie its association with poor prognosis in certain B-cell malignancies.